











P-Rex1 directly activates RhoG to regulate GPCR-driven Rac
signalling and actin polarity in neutrophils
George Damoulakis1,*, Laure Gambardella1, Kent L. Rossman2, Campbell D. Lawson1, Karen E. Anderson1,
Yoshinori Fukui3, Heidi C. Welch1, Channing J. Der2, Len R. Stephens1,` and Phillip T. Hawkins1,`,§
ABSTRACT
G-protein-coupled receptors (GPCRs) regulate the organisation of
the actin cytoskeleton by activating the Rac subfamily of small
GTPases. The guanine-nucleotide-exchange factor (GEF) P-Rex1
is engaged downstream of GPCRs and phosphoinositide 3-kinase
(PI3K) in many cell types, and promotes tumorigenic signalling and
metastasis in breast cancer and melanoma, respectively. Although
P-Rex1-dependent functions have been attributed to its GEF activity
towards Rac1, we show that P-Rex1 also acts as a GEF for the
Rac-related GTPase RhoG, both in vitro and in GPCR-stimulated
primary mouse neutrophils. Furthermore, loss of either P-Rex1 or
RhoG caused equivalent reductions in GPCR-driven Rac activation
and Rac-dependent NADPH oxidase activity, suggesting they
both function upstream of Rac in this system. Loss of RhoG also
impaired GPCR-driven recruitment of the Rac GEF DOCK2, and F-
actin, to the leading edge of migrating neutrophils. Taken together,
our results reveal a new signalling hierarchy in which P-Rex1, acting
as a GEF for RhoG, regulates Rac-dependent functions indirectly
through RhoG-dependent recruitment of DOCK2. These findings
thus have broad implications for our understanding of GPCR
signalling to Rho GTPases and the actin cytoskeleton.
KEY WORDS: Cell signalling, Cell migration, NADPH oxidase,
Neutrophil, Rho GEF, Small GTPase
INTRODUCTION
Rac proteins (Rac1, Rac2 and Rac3), a subgroup within the Rho
family of small GTPases, regulate key aspects of the cytoskeletal
reorganisation necessary for cell motility, migration, adhesion
and morphological changes. They undergo rapid spatio-
temporally co-ordinated cycles of activation and inactivation
that are linked to upstream signalling pathways by several classes
of guanine-nucleotide-exchange factor (GEF) (Rossman et al.,
2005). Crucially, recent studies have revealed crosstalk between
different Rho GTPase subfamilies and isoforms as key to their
function in different cellular and subcellular contexts (Hung et al.,
2013; Sanz-Moreno et al., 2008). In addition to cell migration
during normal development and immunity, deregulation of these
processes drives cancer invasion and metastasis, and there is
strong evidence that mutations in Rac1 and Rac GEFs are
associated with disease initiation and/or progression (Berger
et al., 2012; Hodis et al., 2012; Lindsay et al., 2011; Nishihara
et al., 2002; Sanz-Moreno et al., 2008).
G-protein-coupled receptors (GPCRs) are acute regulators of
cell movement, but the mechanisms by which they regulate GTP/
GDP exchange on Rac proteins are still poorly understood,
although several lines of evidence point to a pivotal role for
PtdIns(3,4,5)P3 generated by the class I phosphoinositide 3-
kinase (PI3K) signal transduction pathway (Stephens et al.,
2008). P-Rex1 was identified as a PtdIns(3,4,5)P3-dependent Rac
GEF activity that is synergistically regulated by PtdIns(3,4,5)P3
and the bc subunits of receptor-coupled heterotrimeric G proteins
(Barber et al., 2007; Hill et al., 2005; Welch et al., 2002), and
subsequent studies have assumed that this is its major catalytic
function in cells. However, despite P-Rex1 being ideally placed
to transduce GPCR-driven signals directly through Rac,
neutrophils from P-Rex12/2 mice display only partial defects in
Rac-dependent functions (Dong et al., 2005; Welch et al., 2005).
This suggests that the P-Rex1-mediated regulation of Rac
signalling is more complex or context-dependent than the
conceptually satisfying idea of P-Rex1 as the direct dominant
link between GPCRs and Rac activation. Mutations in the related
P-Rex2 gene have recently been identified as drivers of
melanoma, and genetic deletion of P-Rex1 reduced metastasis
of N-Ras-driven melanoma in mice (Berger et al., 2012; Lindsay
et al., 2011). P-Rex2 has also been shown to inhibit the tumour
suppressor and PtdIns(3,4,5)P3 phosphatase, PTEN (Fine et al.,
2009). In light of these findings, the task of understanding
the biology of P-Rex family GEFs, and their control of Rac-
dependent functions, becomes all the more pressing.
Neutrophils are an attractive model for studies into actin dynamics
because they exhibit a rapid, amoeboid form of migration
characteristic of many cell types, including other leukocytes, stem
cells and some tumour cells (Kay et al., 2008; Sanz-Moreno et al.,
2008; Stephens et al., 2008). In addition to regulating the neutrophil
cytoskeleton, Rac proteins are known to be essential components of
the NADPH oxidase complex, responsible for the generation of
microbicidal reactive oxygen species (ROS) (Dinauer, 2003).
Neutrophils respond robustly and rapidly to a variety of GPCR
ligands, making them ideal for biochemical studies of GPCR-driven
GEF and GTPase function in primary cells.
RhoG is a fourth member of the Rac subfamily, but does not
directly interact with classical, CRIB-domain-containing Rac1, 2
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and 3 effectors. Instead, it has been reported to function upstream
of Rac in some systems by recruiting a bipartite Rac GEF
complex comprising members of the DOCK (isoforms 1–5) and
ELMO (isoforms 1–3) families (Côté et al., 2002; Katoh and
Negishi, 2003). In addition to roles in EGF-dependent cell
migration, neurite outgrowth, endocytosis and leukocyte trans-
endothelial migration, RhoG is required for efficient activation of
the NADPH oxidase by GPCR ligands in mouse neutrophils
(Bass et al., 2011; Condliffe et al., 2006; Hiramoto-Yamaki et al.,
2010; Samson et al., 2010; van Buul et al., 2007). Furthermore,
mouse neutrophils lacking DOCK2, the major DOCK protein in
neutrophils, have severe defects in GPCR-stimulated ROS
production and cell migration (Kunisaki et al., 2006).
In light of the above work, we set out to explore the
relationship between RhoG and Rac activation downstream of
GPCRs, using a combination of biochemical and genetic
approaches. Our data suggest that, contrary to the prevailing
view of its function, P-Rex1 acts as a GEF for RhoG downstream
of GPCR engagement in mouse neutrophils, and regulates Rac-
driven processes indirectly in this system by promoting RhoG-
dependent recruitment of the Rac GEF DOCK2.
RESULTS
RhoG is activated by the G-protein-coupled fMLP receptor
through a PI3Kc-dependent mechanism
There is evidence for a role of RhoG downstream of GPCR
engagement in neutrophils (Condliffe et al., 2006); however, its
activation and regulation has yet to be measured in any GPCR-
driven system. In order to assess the regulation of RhoG
downstream of GPCRs, we developed a refined procedure for
purifying primary mouse neutrophils in a quiescent state that
allows them to respond robustly and rapidly to GPCR ligands,
such as the formylated peptide N-formyl-methionyl-leucyl-
phenylalanine (fMLP), with minimal pre-activation by autocrine
or paracrine factors (see Materials and Methods). Stimulation of
mouse neutrophils with fMLP resulted in a rapid transient rise in
Fig. 1. RhoG is activated downstream of the G-protein-coupled fMLP receptor through a PI3Kc- and P-Rex1-dependent mechanism in primary mouse
neutrophils. RhoG and Rac activation were measured by affinity pulldown (using GST–ELMO1 and GST–PAK-CRIB, respectively) and GTP-RhoG and GTP-
Rac levels were normalised to total RhoG or Rac levels. (A–C) Neutrophils from WT mice were incubated in the presence or absence of 100 nM wortmannin
(WM), and stimulated with 10 mM fMLP for the indicated times. Data are mean6s.e.m. of four (A) and range of two (B,C) independent experiments.
(D) Neutrophils from WT and PI3Kc2/2 mice were stimulated with 10 mM fMLP for 10 s. Data are mean6s.e.m. of four independent experiments.
(E,F) Neutrophils from WTand P-Rex12/2 mice (E) or mice null for both P-Rex1 and P-Rex-2 (P-Rex122/2) (F) were stimulated with 10 mM fMLP for 10 s. Data
are mean6s.e.m. of three (E) and range of two (F) independent experiments. (G) Neutrophils from WTand Vav1232/2 mice were stimulated with 10 mM fMLP for
10 s. Data are mean6s.e.m. of four independent experiments. (H) WTand P-Rex122/2 mice were stimulated with 10 mM fMLP for the indicated times. Data are
mean6s.d. of three independent experiments. *P#0.05, **P#0.01, by an unpaired Student’s t-test.












the levels of GTP-RhoG, peaking at 10 s and returning to basal
levels within 1 min (Fig. 1A). This response was acutely sensitive
to the pan-PI3K inhibitor wortmannin, suggesting GPCR-driven
activation of RhoG requires PtdIns(3,4,5)P3 synthesis by class I
PI3Ks. This was supported by measurements in neutrophils from
PI3Kc2/2 mice, which revealed that fMLP-driven activation of
RhoG was significantly dependent on PI3Kc (Fig. 1D), consistent
with previous studies identifying PI3Kc as the dominant class I
PI3K activity downstream of GPCRs in mouse neutrophils
(Hirsch et al., 2000; Li et al., 2000; Sasaki et al., 2000). Under
equivalent conditions, fMLP-stimulated formation of GTP-Rac1
and -Rac2 exhibited similar kinetics and wortmannin-sensitivity
as did formation of GTP-RhoG (Fig. 1B,C), suggesting these
responses might be linked.
P-Rex1 is required for fMLP-driven activation of RhoG
Certain GEFs for Rac have been identified as GEFs for RhoG in
other cell systems, including members of the Vav family (Samson
et al., 2010). P-Rex1 and Vav1 have also been identified as major
regulators of fMLP-stimulated Rac1/2 activation in neutrophils
(Lawson et al., 2011; Welch et al., 2005), and therefore we
investigated the role of these two GEF families in the regulation
of RhoG. Strikingly, we found that loss of P-Rex1 (P-Rex12/2)
severely impaired fMLP-driven RhoG activation (Fig. 1E),
whereas loss of all three Vav isoforms had no significant effect
(Fig. 1G). The major isoform of P-Rex in mouse neutrophils is P-
Rex1, with no functional role previously identified in these cells
for P-Rex2 (Donald et al., 2004). Consistent with this,
neutrophils with loss of both P-Rex1 and P-Rex2 displayed a
defect in RhoG activation similar to that seen in neutrophils from
P-Rex12/2 mice (Fig. 1F).
Neutrophils express high levels of many GPCRs allowing them
to respond rapidly to a variety of stimuli. To assess whether the
dependence of RhoG activity on P-Rex is a more general feature
of GPCR signalling in neutrophils, or specifically downstream
of the fMLP receptor, we treated mouse neutrophils with the
complement factor C5a, a potent inflammatory mediator and
neutrophil chemoattractant. Like fMLP, C5a induced rapid
activation of RhoG that was strongly P-Rex-dependent (Fig. 1H).
These results suggest that P-Rex1 is upstream of RhoG
activation in the pathway downstream of GPCR engagement in
neutrophils. However, positive-feedback loops are known to play
a role in GPCR signalling to Rho-family GTPases (Stephens
et al., 2008) and can obfuscate the interpretation of signalling
data. We tested the potential role of such feedback at three
levels. First, we assessed whether RhoG activation required the
presence of Rac2. We found that fMLP-driven RhoG activity
was not reduced in neutrophils from Rac22/2 mice (Fig. 2A),
indicating that regulation of RhoG activity by P-Rex1 is not an
indirect consequence of P-Rex1 activity towards Rac2. Second,
we assessed fMLP-driven class I PI3K activity. We found no
difference in fMLP-stimulated PtdIns(3,4,5)P3 accumulation
between wild-type (WT) and RhoG2/2 mice (Fig. 2B),
confirming that RhoG functions downstream of PI3Kc in
this system. Third, we used latrunculin B to block actin
polymerisation, and measured its effect on fMLP-induced RhoG
activity. We observed no reduction in RhoG activation under
these conditions suggesting that actin polymerisation is not
required to initiate signalling through P-Rex1 or RhoG (Fig. 2C).
P-Rex1 is an efficient GEF for RhoG in vitro
Previous work has indicated that P-Rex1 can act as a GEF for Rac
proteins in vitro but its activity towards RhoG has not been
reported. We therefore investigated the substrate specificity of P-
Rex1 in vitro in more detail. We first employed a mant-GTP
incorporation assay using a panel of His6-tagged Rho family
GTPases as substrates for the purified P-Rex1 DH-PH domain. In
this assay, P-Rex1 exhibited substantial exchange activity
towards Rac1/2 and Cdc42 (Fig. 3A,B,E), as previously shown
(Welch et al., 2002), as well as Rac3 (Fig. 3C), the Cdc42-like
Rho protein TC10 (Fig. 3F) and, importantly, RhoG (Fig. 3D).
Full-length P-Rex1 (purified from baculovirus-infected Sf9 cells)
Fig. 2. Positive feedback through Rac2, PtdIns(3,4,5)P3 and F-actin are not responsible for regulation of RhoG activity by P-Rex1. (A) Neutrophils from
WT and Rac22/2 mice were stimulated with 10 mM fMLP for 10 s. RhoG activation was measured by affinity pulldown using GST–ELMO1. Data are
mean6range of two independent experiments. (B) PtdIns(3,4,5)P3 was measured by LC-ESI/MS and normalised to the levels of PtdIns(4,5)P2. Data are
mean6s.e.m. of three independent experiments. (C) Neutrophils from WT and RhoG2/2 mice were incubated for 10 min in the presence or absence of 25 mM
Latrunculin B (LatB) and stimulated for the indicated times with 10 mM fMLP. Data are mean6s.e.m. of four independent experiments. *P#0.05 by an unpaired
Student’s t-test.












was also able to act as an efficient GEF for RhoG, as well as
Rac1, using an alternative assay, based on immunoprecipitation
of [35S]GTPcS-loaded and EE-tagged lipid-modified RhoG
(Fig. 3L).
These results suggest that P-Rex1 has relatively broad substrate
specificity and the potential to act as an efficient GEF for RhoG,
Rac1, Rac2 and Rac3, Cdc42 and TC10, but not RhoA, RhoB and
RhoC or TCL (Fig. 3G–J). Transcriptome analysis of mouse
neutrophils suggests TC10 is not expressed in these cells (our
unpublished observations). Although Cdc42 is known to have a
role in neutrophils, we could not detect fMLP-driven Cdc42
activation under conditions where RhoG and Rac were activated,
and levels of GTP-Cdc42 were unaffected in neutrophils from
mice null for both P-Rex1 and P-Rex2 (Fig. 3K).
P-Rex1 and RhoG regulate fMLP-driven Rac activity and
NADPH oxidase
The above data identify P-Rex1 as a dominant GEF, coupling
GPCR activation directly to nucleotide exchange on RhoG. A key
question, therefore, is the extent to which activation of RhoG is
the most important function of P-Rex1 and, additionally, the
relationship of this function to the activation of its alternative
potential substrates Rac1 and Rac2. Separate studies have
previously reported that RhoG and P-Rex1 regulate some Rac2-
dependent neutrophil functions, such as activation of the NADPH
oxidase (Condliffe et al., 2006; Dong et al., 2005; Welch et al.,
2005). However, the relatively small effects of P-Rex1 deletion
observed in these studies contrast with the more severe defects
reported upon RhoG deletion, and thus conflict with our
observation that P-Rex1 is the major regulator of RhoG in this
system. We reasoned that this might be explained by differences
in the experimental conditions used for these studies, and sought
to compare the effects of P-Rex and RhoG deletion directly in
equivalent assays. Under conditions where fMLP stimulation
drives P-Rex-dependent RhoG activation, neutrophils from
RhoG2/2 mice and mice null for both P-Rex1 and P-Rex2
displayed comparable severe defects in fMLP-driven NADPH
oxidase activity (Fig. 4). These defects in ROS formation were
apparent across a range of fMLP concentrations, although they
were proportionately greater at lower doses.
Fig. 3. P-Rex1 directly catalyses guanine nucleotide exchange on RhoG. (A–J) The recombinant DH-PH domain of P-Rex1 was used in fluorescent-based
GEF assays that monitor the incorporation of mant-GTP into bacterially expressed Rho family GTPases. Guanine nucleotide exchange on the indicated Rho
family GTPase (2 mM) was assessed in the presence (red circles) or absence (blue squares) of P-Rex1 (200 nM). Arrows indicate time of P-Rex1 addition. Data
shown are representative of two independent experiments. (K) Isolated BM neutrophils from WT mice and mice null for both P-Rex1 and P-Rex-2 (P-Rex122/2)
were stimulated with 10 mM fMLP for 10 s. Cdc42 activation was measured by affinity pulldown using GST–PAK-CRIB. Data are mean6s.e.m. of three
independent experiments. (L) Recombinant, Sf9-derived EE-RhoG and Rac1 were incubated for 10 min with or without EE–P-Rex1, in the presence of anionic
liposomes and PtdIns(3,4,5)P3, and the incorporation of [
35S]GTPcS was assessed by immunoprecipitation of EE–RhoG or –Rac1 and liquid scintillation
counting of bound radionucleotide. As a positive control for nucleotide-binding capability, GTPases were incubated for 10 min in the presence of EDTA. Data are
mean6s.e.m. of three independent experiments performed in duplicate *P#0.05 by an unpaired Student’s t-test.












Stimulation of neutrophils with a sub-maximal dose of fMLP
(1 mM) elicited rapid formation of GTP-Rac1 and GTP-Rac2
(Fig. 5A,B) that was substantially (§50%) reduced in neutrophils
from both RhoG2/2 mice and mice null for both P-Rex1 and P-
Rex2 (Fig. 5C–F). Neutrophils from mice null for all three Vav
isoforms (Vav1, Vav2 and Vav3) also displayed partially reduced
Rac1 (but not Rac2) activation under these conditions (Fig. 5G,H).
At a higher dose of fMLP (10 mM), and consistent with previously
published data, the effects of RhoG and P-Rex deletion were
significantly smaller (Fig. 6A–D), suggesting stimulus-strength-
dependant redundancy is present in this system and that other, P-
Rex- and/or RhoG-independent, routes to Rac activation can be
engaged by the fMLP receptor. In this regard, and again consistent
with previously published data (Kim et al., 2003; Lawson et al.,
2011), neutrophils from mice null for all three Vav isoforms also
displayed partially reduced Rac activation at 10 mM fMLP
(Fig. 6E,F). The equivalence in effects of RhoG or P-Rex
deletion on either fMLP-stimulated formation of ROS or GTP-
Rac1 and -Rac2, suggests that the major role for P-Rex in this
signalling network is to regulate RhoG and implies that P-Rex1 can
regulate Rac1 and Rac2 indirectly in this system through an effect
on RhoG. Furthermore, given the much bigger effects of RhoG
deletion on ROS formation than activation of Rac1 and Rac2, they
also suggest some channelling of a Rac1 and Rac2 pool to the
oxidase must occur, or that some effects of P-Rex1 and/or RhoG
are not through Rac1 or Rac2 alone.
RhoG regulates fMLP-driven translocation of DOCK2
We next sought to identify the mechanism by which P-Rex1 and
RhoG signalling might control Rac activation in neutrophils. Of
the few identified RhoG effector proteins, only those of the
ELMO family have been convincingly demonstrated to mediate
RhoG-dependent processes in cells (Ho et al., 2009; Katoh and
Negishi, 2003). ELMO proteins exist constitutively bound to
members of the DOCK family and, together, they form a bipartite
GEF complex that catalyses nucleotide exchange on Rac through
the DOCK DHR-2 domain (Brugnera et al., 2002; Kulkarni et al.,
2011; Lu et al., 2004; Lu et al., 2005). DOCK2, a major DOCK
isoform in leukocytes, has been shown to be a crucial regulator of
GPCR-driven Rac activity in neutrophils (Kunisaki et al., 2006;
Nishikimi et al., 2009). Using neutrophils from mice expressing a
germline-encoded DOCK2–GFP transgene, the authors of those
studies demonstrated that DOCK2 translocation to the plasma
membrane in fMLP-stimulated neutrophils is PI3K-dependent
and in part mediated by the DOCK2 DHR-1 domain known to
bind PtdIns(3,4,5)P3 (Côté et al., 2005). However, a DHR-1-
independent input into DOCK2 translocation, as observed in
those studies, remains unaccounted for.
We reasoned that RhoG might regulate fMLP-driven Rac activity
in neutrophils by promoting DOCK2 recruitment to the plasma
membrane, presumably through an interaction with ELMO. We
tested this hypothesis by crossing DOCK2–GFP and RhoG2/2 mice,
to generate DOCK2–GFP-expressing RhoG2/2 mice and DOCK2–
GFP-expressing WT controls, and examined the translocation of
DOCK2–GFP to the plasma membrane in neutrophils undergoing
fMLP-induced chemokinesis on glass coverslips using spinning disc
confocal microscopy. Counterstaining with the membrane dye Cell
Mask Orange allowed us to control for any increases in membrane
density associated with membrane ruffling.
Over the course of these experiments, we observed two discrete
classes of DOCK2–GFP translocation events, which we termed
‘small’ and ‘large’. Both WT and RhoG2/2 neutrophils were able
to form small DOCK2–GFP-positive protrusions (Fig. 7A,B).
However, large DOCK2–GFP translocation events were only
observed in WT neutrophils. These data indicate that RhoG
promotes translocation of DOCK2 to the plasma membrane and
thus provide a mechanistic basis for P-Rex1- and RhoG-mediated
control of fMLP-driven Rac activity in neutrophils.
Fig. 4. RhoG and P-Rex regulate fMLP-driven
NADPH oxidase activity in primary mouse
neutrophils. Neutrophils from WT mice and mice
null for both P-Rex1 and P-Rex-2 (P-Rex122/2)
(A,B) or RhoG2/2 mice (C,D) mice were stimulated
with the indicated doses of fMLP, and production of
reactive oxygen species (ROS) measured by
luminol-dependent chemiluminescence in the
presence of HRP. Data are presented as
representative kinetic traces of the rate of ROS
synthesis [relative light units (RLU) per second] from
experiments using 10 mM fMLP (A,C), and total
integrated ROS levels (B,D). Data are mean6s.e.m.
of three (B) and 6 range of two (D) independent
experiments.











ceRhoG regulates fMLP-driven polarisation of F-actin
Neutrophils from DOCK22/2 mice exhibit a profound defect in
their ability to concentrate F-actin at the leading edge upon
treatment with fMLP (Kunisaki et al., 2006), presumably due to
the loss of Rac activity that would normally be localised to this
region. This spontaneous polarisation appears to be independent
of agonist gradients, and follows a rapid global spike in actin
polymerisation that is unaffected by loss of DOCK2. Given that
our data suggest that RhoG can act as an upstream regulator
of DOCK2-driven Rac activity, we visualised the distribution of
F-actin in fMLP-stimulated neutrophils to assess whether loss of
RhoG affects this polarisation process. Cells were stimulated
in suspension, to allow spontaneous polarisation, then fixed
and stained with TRITC–phalloidin, allowing us to visualise and
calculate the distribution of F-actin by wide-field
epifluorescence microscopy (Fig. 7C,G). As in previous studies
of this process, rapid actin polymerisation (,15 s post-fMLP
treatment) could be visualised as a bright ring of phalloidin
staining that marked out the entire cell perimeter. Consistent
with a previously reported lack of effect of DOCK2, this event
Fig. 5. RhoG and P-Rex regulate Rac activity driven by low doses of agonist in primary mouse neutrophils. (A,B) Isolated BM neutrophils from WT mice
were stimulated with 1 mM fMLP for the indicated times. (C–H) Isolated BM neutrophils from WT mice, mice null for both P-Rex1 and P-Rex-2 (P-Rex122/2)
(C,D), and RhoG2/2 mice (E,F) or mice null for all three Vav isoforms (Vav1232/2) (G,H) were stimulated with 1 mM fMLP for 10 s. Activation of Rac1
and Rac2 were measured by affinity pulldown using GST–PAK-CRIB. Levels of GTP-bound Rac1 or RAc2 were normalised to the total Rac1 and Rac2 level.
Images of representative western blots are also presented. Data are mean6s.e.m. of four (A–C), three (D), five (E) and three (F–H) independent experiments.
*P#0.05, **P#0.01 by an unpaired Student’s t-test.












was unaffected by RhoG deletion. FACS analysis of total
cellular F-actin levels also confirmed that loss of RhoG does not
significantly curtail global fMLP-driven actin polymerisation
(Fig. 7D). Polarisation of F-actin began at ,30 s and was
largely complete by 2 min. At 1 and 2 min, both the number of
cells exhibiting F-actin polarisation, and the extent of F-actin
polarisation, were significantly reduced in RhoG2/2 neutrophils
compared to WT neutrophils (Fig. 7E,F). These results are
consistent with a role for RhoG in controlling the localisation
and activity of DOCK2 during fMLP-mediated neutrophil
polarisation.
DISCUSSION
GPCRs elicit rapid changes in cell behaviour by modulating the
activity of, and interplay between, multiple small GTPases,
particularly those of the Rho family. The study of rapid GTPase
regulation is central to our understanding of dynamic cellular
processes, such as actin remodelling, secretion and redox
signalling.
Our data reveal RhoG activation as a rapid and crucial event
in GPCR-driven neutrophil function, and identify P-Rex1 as the
major GEF responsible for guanine nucleotide exchange on
RhoG in this system. This is the first study to successfully
Fig. 6. Effect of Vav deletion on Rac activity predominates at
high doses of agonist. Isolated BM neutrophils from WT mice
and mice null for both P-Rex1 and P-Rex-2 (P-Rex122/2)
(A,B), RhoG2/2 mice (C,D) or mice null for all three Vav isoforms
(Vav1232/2) (E,F) were stimulated with 10 mM fMLP for 10 s.
Activation of Rac1 and Rac2 were measured by affinity pulldown
using GST–PAK-CRIB. Levels of GTP-bound Rac1 or Rac2
were normalised to the total Rac1 and Rac2 level. Images of
representative western blots are also presented. Data are
mean6range of two (A,B,E,F) independent experiments.












measure RhoG activation downstream of GPCRs, and both
the speed of this response and its strong dependence on
PI3Kc and P-Rex1 indicate a proximal relationship to receptor
activation. Thus previous work has demonstrated synergistic
regulation of P-Rex by bc subunits of G proteins (derived
from Gi) and PtdIns(3,4,5)P3 (derived from Gbc-stimulated
PI3Kc) (Barber et al., 2007; Hill et al., 2005; Welch et al.,
2002).
It has been widely reported in other systems that RhoG can
signal to Rac by recruiting DOCK proteins through their adaptor
ELMO (Hiramoto et al., 2006; Katoh and Negishi, 2003). The
striking defect we observed in DOCK2 recruitment to the leading
edge of polarised neutrophils upon loss of RhoG indicates that
this mechanism is also responsible for linking RhoG and Rac
downstream of GPCRs in neutrophils. It is also consistent with
previous data indicating P-Rex2/2 (Dong et al., 2005; Welch
et al., 2005), RhoG2/2 (Condliffe et al., 2006) and DOCK22/2
(Kunisaki et al., 2006) neutrophils all display defects in GPCR-
induced Rac activity and ROS production. This new pathway for
GPCR-mediated control of Rac thus unifies a number of
confusing observations in the field of Rho family signalling, by
indicating a hierarchical, rather than simply cooperative
organisation of GEF input into Rac activation (Fig. 8). This
pathway plays an important role in total cellular Rac activation at
lower doses of agonist and is important for GPCR-stimulated
ROS formation and actin polarisation.
Fig. 7. RhoG regulates fMLP-induced
DOCK2 translocation and F-actin
polarisation to the leading edge of primary
mouse neutrophils. (A,B) Neutrophils from
DOCK2–GFP-expressing control (WT) and
RhoG2/2 mice were pre-labelled with the
membrane dye CMO, stimulated with 10 mM
fMLP and imaged by confocal microscopy.
Representative images of ‘large’ and ‘small’
DOCK2–GFP translocation events in WT and
RhoG2/2 neutrophils are shown (A). Note that
no ‘large’ translocation events were observed in
neutrophils from RhoG2/2 mice. Events in
neutrophils from five WT and three RhoG2/2
mice (average 11 cells per mouse) were
counted and presented as pooled data (B).
Data are mean6s.e.m. (C) Diagrammatic
illustration of polarisation efficiency (EP)
calculation. EP was determined as the ratio of
mean fluorescence intensity (MFI) at the front
versus the sides of each cell (Ay/Ax)21.
(D) Neutrophils from WT and RhoG2/2 mice
were stimulated with 10 mM fMLP for the
indicated times before being fixed,
permeabilised and stained with TRITC–
phalloidin. Total F-actin levels, measured by
flow cytometry, are presented as MFI. Data are
mean6s.e.m. of three independent
experiments performed in duplicate.
(E–G) Neutrophils from WT and RhoG2/2 mice
were stimulated with 10 mM fMLP for the
indicated times before being fixed,
permeabilised, stained with TRITC–phalloidin
and imaged by wide-field epifluorescence
microscopy. The percentage of cells deemed to
have polarised (defined as confinement of F-
actin to less than 50% of cell circumference) is
presented (E), along with the quantified
polarisation efficiency (F). Images of
representative cells, from each stage of
analysis, are presented (G) along with the
number of cells (n) analysed at each stage.
Data are mean6s.e.m. of three independent
experiments. *P#0.05, **P#0.01 by an
unpaired Student’s t-test. Scale bars: ,5 mm.












Our data also raise important questions about the more general
role of P-Rex proteins in cells, and challenge the widely held
view that P-Rex acts exclusively on Rac. The broad substrate
selectivity of P-Rex in vitro actually suggests that several Rho-
family GTPases (including Rac and Cdc42) might be potential
substrates for P-Rex in cells. However, given that RhoG functions
upstream of Rac in a variety of systems (Blangy et al., 2000;
Hiramoto et al., 2006; Katoh and Negishi, 2003), many (if not all)
observations of P-Rex-dependent Rac activity could potentially
be driven by the signalling hierarchy revealed here. In particular,
given the recent interest in the role of both P-Rex and DOCK
family members in cancer (Berger et al., 2012; Fine et al., 2009;
Hodis et al., 2012; Lindsay et al., 2011; Sanz-Moreno et al., 2008;
Sosa et al., 2010), it will be important to establish in this context
whether RhoG is responsible for linking these two GEF families
in a common pathway to Rac activation.
Many seminal studies of GEF and GTPase function have
relied on overexpression systems using constitutively active or
dominant-negative mutants, which might not always reflect
events at the endogenous level. In the present study, we made
use of the acute GPCR-sensitivity of primary neutrophils, which
allowed us to measure activation of endogenous GTPases and
assess the involvement of upstream regulators through their
genetic deletion in mice. In addition, this approach provides
further clarity in the interpretation of data on several fronts. First,
GTPase activation events happen within a few seconds, rather
than minutes, hours or days, reducing the probability that our
measurements reflect convoluted homeostatic responses to cell
stimulation, such as well-documented feedback loops (Stephens
et al., 2008). Second, stimulation of quiescent neutrophils in
suspension allowed us to measure at least some GPCR-driven
signalling events (GTP-RhoG and -Rac, and ROS formation) with
precision and in isolation, with minimal interference from
background signals generated by autocrine or paracrine factors
and/or adhesion to tissue culture plate surfaces. Even within this
relatively simple context, it is clear that the organisation of Rac
activation downstream of GPCRs is complex, involving both
the P-Rex1–RhoG–DOCK2 pathway described here, parallel
activation of Vav family GEFs (Turner and Billadeau, 2002) and,
possibly, other pathways of DOCK2 activation [in this regard an
analogous DOCK180–ELMO complex has recently been shown
to be activated directly by Gbc subunits in fibroblasts (Fritsch
et al., 2013)]. The additional properties conveyed by this type of
organisation (involving multiple inputs into the same GEF and,
also, multiple GEFs) are still unclear, but they are likely to
include both amplification of pathways to Rac (conveying
sensitivity) and, through the specific molecular properties of the
constituents, the coupling of Rac to molecular processes that are
distinct to each particular Rac GEF involved (conveying
specificity). The idea that GEFs are recruited into different
molecular complexes, the composition of which depends on the
precise context of cell stimulation, also naturally provides a
mechanism whereby P-Rex, and indeed many other GEFs acting
on Rho family GTPases, exhibit broad substrate specificity in
vitro, but can be directed to different specific substrates in cells. It
also allows a simple mechanism for the ‘streaming’ of pools of
GTP-Rac to specific effectors, such as the NADPH oxidase. This
picture, however, is still largely based on deduction, and a clear
challenge for future studies in this field is to directly observe
distinct GEF–GTPase interactions at the endogenous level, in a
manner that appreciates their spatial and temporal specificity.
MATERIALS AND METHODS
Animals
RhoG2/2 mice (Vigorito et al., 2004) on a mixed C57BL/6J6129/Sv
background were selected, by PCR genotyping, from litters born to
heterozygous parents. WT littermates were used as controls where
possible. PI3Kc2/2 mice on a 129/Ola background were obtained as
described previously (Hirsch et al., 2000) and WT controls were bred in
parallel. Mice null for all three Vav isoforms (Vav1232/2) on a B10/Br
background were generated by breeding Vav12/2, Vav22/2 and Vav32/2
mice as described previously (Fujikawa et al., 2003) and WT B10Br mice
were used as controls. P-Rex12/2 mice and mice null for both P-Rex1 and
P-Rex2 (P-Rex122/2) on a mixed C57BL/6J6 129/Sv background were
obtained as described previously (Donald et al., 2008; Welch et al., 2005)
and WT controls were bred in parallel. Rac22/2 mice on a C57BL/6J
background were obtained as described previously (Roberts et al., 1999)
and WT C57BL/6 mice were obtained from the Babraham Institute
Biological Services Breeding Unit for use as controls. Mice were used at
between 8–20 weeks of age and age-matched where possible. RhoG2/2,
PI3Kc2/2, P-Rex12/2, P-Rex122/2 and associated WT control mice were
housed in individually ventilated cages in a barriered animal facility.
Vav1232/2, Rac22/2 and associated WT control mice were housed in the
same facility but within isolators under specific opportunistic pathogen-
free conditions. DOCK2–GFP mice (Kunisaki et al., 2006) on a C57BL/6J
background were bred with RhoG2/2 for at least two generations and
DOCK2–GFP6RhoG2/2 used for experiments along with DOCK2–GFP
6RhoG+/+ littermates as controls. All mouse work was submitted to and
approved by the Animal Welfare Ethics Committee at the Babraham
Institute under Home Office Project License PPL 80/2335.
Fig. 8. Activation of Rac by the fMLP
receptor in mouse neutrophils.
Activation of the Gi-coupled GPCR for
fMLP releases Gbc subunits, which then
synergise with PI3Kc-generated
PtdIns(3,4,5)P3 to activate P-Rex1,
resulting in the formation of GTP-RhoG
and RhoG-dependent activation of the
Rac GEF DOCK2. PtdIns(3,4,5)P3 has
also been shown to localise the ELMO–
DOCK2 complex to the leading edge of
neutrophils and, thus, has multiple
inputs into the localisation of Rac
activity. The bold arrows represent a
direct regulatory input, the broken
arrows represent an indirect or less
certain regulatory input.












Isolation and preparation of primary neutrophils from mouse
bone marrow
For measurements of PtdIns(3,4,5)P3 and Rac-GTP levels, mouse bone
marrow was suspended in HBSS (without Ca2+ and Mg2+), supplemented
with 15 mM HEPES and 0.25% endotoxin/fatty acid free BSA (HBSS++),
and centrifuged (326 g at room temperature). Cells were re-suspended and
separated by centrifugation (1640 g at room temperature) for 30 min on
discontinuous gradients comprising 62% and 55% Percoll (Amersham).
Neutrophils (70–95% pure, assessed by cytospin) were harvested from the
62%–55% interface and remaining erythrocytes removed by ammonium
chloride lysis (130 mM NH4Cl, 5 mM KCl, 0.78 mM Na2HPO4,
0.176 mM KH2PO4, 5.5 mM glucose, 1 mM MgCl2, 0.28 mM MgSO4,
1.54 mM CaCl2, 13.4 mM NaHCO3) for 1–2 min. Cells were washed
twice with HBSS++ and once with Dulbecco’s PBS containing Ca2+ and
Mg2+, supplemented with 1 g/l glucose and 4 mM NaHCO3 (D-PBS++),
and re-suspended in an appropriate volume of D-PBS++ depending on the
assay. Where possible, bone marrow from two or more mice (per
genotype) was combined to reduce variation between individual mice.
Each pooled preparation was treated as an independent experiment (see
figure legends).
For measurements of RhoG-GTP, Cdc42-GTP, F-actin and ROS levels
and DOCK2 translocation, we refined our neutrophil isolation procedures
to reduce basal activation by autocrine and/or paracrine factors, which we
found necessary to obtain a reproducible measure of GTP-RhoG in
resting cells. Mouse bone marrow was suspended in ice cold HBSS++
and separated by centrifugation (1640 g at 4 C̊) for 30 min on
discontinuous gradients comprised of HBSS++ and 58% Percoll. Non-
granulocytic leukocytes were removed from the HBSS++–Percoll
interface and erythrocytes removed by ammonium chloride lysis. Cells
(60–80% pure, assessed by cytospin) were then washed once (326 g at
4 C̊) in HBSS++ and re-suspended at 16107/ml in D-PBS++. Cell
suspensions were incubated for 2 min at 37 C̊ prior to stimulation except
where treatment with inhibitors was required. Inhibitor treatments were
all performed at 37 C̊ as follows: 100 nM wortmannin for 5 min, 20 mg/
ml Latrunculin B for 10 min.
Measurement of endogenous PtdIns(3,4,5)P3 levels
Mouse primary neutrophils, isolated as described above, were
equilibrated to 37 C̊ and 16106 cells stimulated with 10 mM fMLP for
the indicated periods of time. Cells were then lysed, and lipids extracted,
derivatised and analysed by LC-ESI/MS as described previously (Clark
et al., 2011).
Measurement of endogenous RhoG, Rac1 and Rac2 activity
Mouse primary neutrophils (16107 cells/ml in D-PBS++) were
equilibrated to 37 C̊ and 26106 cells stimulated, with indicated
concentrations of fMLP or C5a, and incubated at 37 C̊ for the periods
of time described. Cells were suspended in a 1 ml final volume of ice-
cold GST-FISH buffer (10% glycerol, 50 mM Tris-HCl pH 7.4, 100 mM
NaCl, 1% NP40, 2 mM MgCl2, 20 mM NaF) and incubated for 3 min on
ice. Lysates were centrifuged (13,000 g for 3 min at 4 C̊) and 50 ml
aliquots taken to assess total levels of RhoG or Rac. A 750 ml volume of
the remaining supernatant was added to 20 ml of glutathione–Sepharose-
4B beads, containing approximately 20–50 mg of GST–ELMO1 (for
detection of GTP-RhoG) or GST–PAK-CRIB (for detection of GTP-
bound Rac1 and Rac2), and incubated with rotation for 15 min at 4 C̊.
Beads were washed three times in GST-FISH buffer and suspended in
Laemmli sample buffer. Samples were separated by 12% SDS-PAGE and
analysed by western blotting.
Guanine-nucleotide-exchange assays
A cDNA fragment encoding the DH-PH domains of P-Rex1 (residues
40–405) was subcloned into the vector pProEx HTb (Invitrogen) in frame
with an N-terminal His6 tag. P-Rex1 DH-PH protein was expressed in
Rosetta2 BL21 (DE3) E. coli cells (EMD Biosciences) grown in lysogeny
broth (LB) with AMP and induced with 0.2 mM IPTG for 16 h at 20 C̊
before being purified using a 5-ml HisTrap Fast Flow column (GE
Healthcare). P-Rex1-containing fractions were incubated with tobacco
etch virus protease overnight to release the His6 tag and subsequently
loaded onto an S-200 size exclusion column (GE Healthcare) equilibrated
in 20 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 2 mM DTT
and 10% glycerol. Fractions containing purified P-Rex1 DH-PH protein
were pooled, concentrated, snap frozen in liquid N2 and stored at 280 C̊.
His6-tagged RhoGTPases were expressed and purified as described
previously (Mitin et al., 2007).
N-methylanthraniloyl (mant)-GTP incorporation into bacterially
expressed and purified RhoGTPases was carried out with a FluoroMax-
4 spectrometer (Horiba) at 20 C̊ as described previously (Mitin et al.,
2007). Exchange-reaction assay mixtures containing 20 mM Tris-HCl
pH 7.5, 200 mM NaCl, 5 mM MgCl2, 1 mM DTT, 5% (v/v) glycerol,
400 nM mant-GTP (Invitrogen) and 2 mM of the relevant GTPase were
prepared and allowed to equilibrate with continuous stirring. After
equilibration, P-Rex1 DH-PH protein was added at 200 mM and the
fluorescence intensity (lemission, 360 nm; lexcitation, 440 nm) was
monitored.
An alternative, immunoprecipitation-based assay was also performed
in a small number of experiments using recombinant full-length EE-
tagged P-Rex1 (purified from baculovirus-infected Sf9 cells) and
[35S]GTPcS-loading of EE-tagged, lipid-modified RhoG (purified from
baculovirus-infected Sf9 cells using Triton X114), as described
previously (Welch et al., 2002).
Measurement of neutrophil NADPH oxidase activity
ROS production by WT and RhoG2/2 mouse neutrophils was measured
by luminol-dependent chemiluminescence in a plate luminometer, as
described previously (Condliffe et al., 2005). Mouse neutrophils (2.56106
cells/ml in D-PBS++ at 37 C̊) were incubated with 160 mM Luminol in
the presence of 26.7 U/ml horseradish peroxidase (HRP). Samples were
assayed in duplicate and treated as technical replicates.
Measurement of total and polarised F-actin accumulation
Mouse neutrophils were isolated at 4 C̊, suspended (at 56106 cells/ml) in
D-PBS++ with 0.1% BSA and equilibrated for 2 min at 37 C̊. 106 cells
per sample were stimulated, for the indicated periods of time, with
10 mM fMLP and fixed in an equal volume of 4% paraformaldehyde (2%
final) for 15 min at room temperature. Fixed cells were diluted in
an excess volume of D-PBS++ with 0.1% BSA, centrifuged (500 g for
4 min at room temperature) and supernatants discarded. Cells were re-
suspended in 1 ml D-PBS++/2% BSA and centrifuged again.
Supernatants were discarded, cells re-suspended in 200 ml staining
buffer (D-PBS++/0.1% BSA containing 1% Triton X-100 and 50 ng/ml
TRITC-phalloidin) and incubated for 15 min at room temperature. Cells
were then washed twice in D-PBS++ with 2% BSA, suspended in 200 ml
PBS++ with 0.1% BSA and either imaged under wide-field
epifluorescence (Olympus Cell‘R, 606 objective) or analysed on a
FACSCalibur flow cytometer. Cells were scored for polarisation and
polarisation efficiency (EP) was determined as described in Fig. 7.
Imaging of DOCK2 translocation
Mouse neutrophils were isolated at 4 C̊, suspended in D-PBS++ with
0.1% BSA and incubated for 5 min, on ice, in the presence of 1 mg/ml
Cell Mask Orange (Invitrogen). After washing in D-PBS++, cells were
pipetted onto the glass coverslip insert of an imaging ring and
equilibrated to 37 C̊ for 5 min. Cells were then imaged for 7 min,
during which a 10 mM fMLP was applied as a bath stimulation during the
first minute of each movie. Images were acquired on a Nikon Ti-E
confocal microscope with a Yokogawa CSU-10 spinning disk unit, and
captured using an Andor iXon EM-CCD 897 camera. Raw image data
were deconvolved using Huygens Professional software (SVI, Hilversum
NL).
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